作者: S Serke , H Riess , H Oettle , D Huhn
关键词:
摘要: In adults, the haemolytic-uraemic syndrome (HUS) is associated with probable causative factors in minority of all cases. Cytotoxic drugs are one these potential agents. Although metastatic cancer by itself a recognized risk-factor for development HUS, therapy mitomycin-C, cis-platinum, and bleomycin carries significant, albeit extremely small, risk compared other cytotoxic drugs. Gemcitabine novel drug promising activity against pancreatic adenocarcinoma. We reporting on patient duodenal papillary carcinoma developing HUS while weekly gemcitabine therapy. The presenting features this were non-cardiac pulmonary oedema, renal failure, thrombocytopenia haemolytic anaemia. diagnosis was made day admission to institution. Upon aggressive therapy, including single haemodialysis five plasmaphereses, recovered uneventfully, modestly elevated creatinine-values as remnant acute illness. Re-exposure 6 months after episode instituted progressive carcinoma, thus far has not caused another HUS.